Aziz had a pivotal role in the European expansion of Arrow Group being now part of Watson Pharmaceuticals since 2009 for $1.75billion, only 8 years after the business was established. At Arrow Aziz was responsible for all multi-country licensing deals, corporate development; with special focus on entering new markets.
Prior to Arrow, Aziz was Business Development, API and Patent manager for Merck Generiques (now part of Mylan Inc) in France. He was responsible for sourcing, European licensing of injectables and patent strategy for the French market.
Skill Set: Corporate Development Strategy, New Market Entry, Licensing In/Out & BD, Injectable Products, Portfolio, API Sourcing